Press releases
Su | Mo | Tu | We | Th | Fr | Sa |
---|---|---|---|---|---|---|
Su | Mo | Tu | We | Th | Fr | Sa |
---|---|---|---|---|---|---|
-
May 20, 2014BD Signs Agreement with Island Health to Install Microbiology Platform by Fourth Quarter 2014
MISSISSAUGA, ONTARIO, May 20, 2014 – BD (Becton, Dickinson and Company), a leading global medical technology company, today announced an agreement with Island Health to install the BD Kiestra™...
-
May 20, 2014
The Board of Directors of BD (Becton, Dickinson and Company) (NYSE: BDX) has declared a quarterly dividend of 54.5 cents per common share payable on June 30, 2014 to holders of record on June 9,...
-
May 15, 2014
SAN DIEGO, CA, May 15, 2014 /PRNewswire/ – CareFusion Corp. (NYSE: CFN), a leading, global medical technology company, today announced the successful pricing of three series of senior unsecured...
-
May 14, 2014BD Medical - Medical Surgical Systems and BD Medical - Pharmaceutical Systems sites in Columbus push to close skills gap needed by local industry
COLUMBUS, NE, May 14, 2014 – BD Medical, a segment of BD (Becton, Dickinson and Company), a leading global medical technology company, has awarded $12,000 in scholarships to three local high...
-
May 13, 2014Data-driven approach and implementation of BD Vacutainer® Push Button Blood Collection Sets help drive change at Robert Wood Johnson University Hospital
An article published in the Spring 2014 issue of the Journal of the Association of Occupational Health Professionals in Healthcare discusses how a systematic, data-driven approach and the...
-
May 12, 2014BD MAX™ Enteric Parasite Panel Achieves CE Mark to Detect Common and Pathogenic Intestinal ParasitesSupports comprehensive screening for infectious gastroenteritis with the BD MAX™ System
SPARKS, MD, May 12, 2014 – BD Diagnostics, a segment of global medical technology company BD (Becton, Dickinson and Company), announced today the availability of the CE-marked BD MAX™ Enteric...
-
May 8, 20142,000 sq. ft. interactive laboratory environment expansion funded by BD Diagnostics
BALTIMORE, MD, May 8, 2014 – The Maryland Science Center’s newly expanded and re-imagined space, SciLab, is now open, providing a unique, popular and hands-on laboratory science simulation for...
-
May 7, 2014Move Increases Size of Board to 10 Members
SAN DIEGO, CA, May 7, 2014 /PRNewswire/ – CareFusion (NYSE:CFN), a leading global medical technology company, today announced that Supratim Bose has been elected as the 10th member of its board...
-
May 7, 2014
BD Diagnostics, a segment of leading global medical technology company BD (Becton, Dickinson and Company) (NYSE: BDX), announced today the availability of the FDA-cleared BD MAX(TM) Enteric...
-
May 5, 2014Third quarter revenue increased 7 percent to $968 million, driven by continued growth in the company's Procedural Solutions segment
SAN DIEGO, May 5, 2014 /PRNewswire/ – CareFusion Corp. (NYSE: CFN), a leading, global medical technology company, today reported financial results for its third quarter of fiscal 2014, ended...
-
May 2, 2014
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced today that it will present at the Deutsche Bank 39(th) Annual Health Care Conference on...
-
May 1, 2014- Announces revenues of $2.072 billion, an increase of 3.6 percent, or 5.1 percent on a foreign currency-neutral basis.
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today reported quarterly revenues of $2.072 billion for the second fiscal quarter ended March 31, 2014,...
-
Apr 24, 2014Also Introduces the pink Achieve® Breast Biopsy Device
SAN DIEGO, CA, March 24, 2014 – CareFusion (NYSE:CFN), a leading global medical technology company, launched its new AVAflex ® Vertebral Balloon System today at the 39th annual Scientific...
-
Apr 24, 2014Easy-to-use CD4 analysis platform tailored to meet the needs of resource-limited settings
BD Biosciences, a segment of BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the launch of the BD FACSPresto(TM) Near Patient CD4...
-
Apr 22, 2014CareFusion Technology Receives Top Marks for Quality, Ease of Use and Reliability
SAN DIEGO, April 22, 2014 /PRNewswire/ – CareFusion (NYSE:CFN), a leading global medical technology company, today announced that nurses have ranked the Pyxis MedStation® system as the #1...
-
Apr 9, 2014BD MAX™ GC rt PCR Assay Receives CE Mark
BALTIMORE, MD, April 09, 2014 – BD Diagnostics, a segment of BD (Becton, Dickinson and Company), a leading global medical technology company, announced today the CE mark and launch of the BD...
-
Apr 7, 2014
SAN DIEGO, April 7, 2014 /PRNewswire/ – CareFusion Corporation (NYSE: CFN) today announced plans to release third quarter fiscal 2014 results on Monday, May 5, following the close of trading on...
-
Apr 3, 2014
BD (Becton, Dickinson and Company) (NYSE:BDX) announced today that it will conduct a live webcast of its second fiscal quarter 2014 earnings conference call on Thursday, May 1, 2014, at 8:00 a.m....
-
Apr 1, 2014Designed Exclusively for CareFusion by Surgical Site Solutions, Inc.
SAN DIEGO, CA, April 1, 2014 – CareFusion (NYSE:CFN), a leading global medical technology company, today announced availability of the ClipVac® hair removal system from Surgical Site Solutions,...
-
Mar 24, 2014Global Expert on Infectious Disease and Public Health
FRANKLIN LAKES, N.J., March 24, 2014 – BD (Becton, Dickinson and Company) (NYSE:BDX), a leading global medical technology company, announced the election of Dr. Claire Pomeroy to its Board of...
-
Mar 19, 2014CareFusion Places in Top 10 for Overall Software Vendor Rankings
SAN DIEGO, CA, Feb. 19, 2014 /PRNewswire/ – CareFusion (NYSE:CFN), a leading global medical technology company, today announced its MedMined® Surveillance Advisor was named the Category Leader...
-
Mar 19, 2014BD Veritor(TM) System for Rapid Detection of RSV Receives 510(k) Clearance and CLIA Waiver
BD Diagnostics, a segment of BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced today that it received 510(k) clearance and Clinical Laboratory...
-
Mar 6, 2014V. Mueller Bipolar Instruments Promote Improved Safety for Electrosurgical Procedures
SAN DIEGO,CA, March 6, 2014 /PRNewswire/ – CareFusion (NYSE:CFN), a leading global medical technology company, today announced the global launch of a new line of electrosurgical instruments...
-
Feb 25, 2014BD Veritor(TM) System for Rapid Detection of Group A Strep Receives 510(k) Clearance and CLIA Waiver
BD Diagnostics, a segment of BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced today that it received 510(k) clearance and Clinical Laboratory...
-
Feb 18, 2014Infusion pump interoperability collaboration with CareFusion and Cerner wins award for Improving the Patient Experience: Care and Safety
SAN DIEGO, CA and KANSAS CITY, MO, Feb. 18, 2014 /PRNewswire/ – The RFID in Healthcare Consortium (RHCC) and IntelligentHospital.org today announced that Children's Hospitals and Clinics of...
-
Feb 14, 2014
BALTIMORE, MD, February 14, 2014 – BD Diagnostics, a segment of BD (Becton, Dickinson and Company), a leading global medical technology company, announced today that the company has achieved...
-
Feb 11, 2014BD and USAID Collaborate to Support National TB Program Capacity Building and Development Goals
SURABAYA, February 11, 2014 – In an ongoing effort to prevent and control infectious disease outbreaks globally, the U.S. Agency for International Development (USAID) and Becton, Dickinson and...
-
Feb 7, 2014
FRANKLIN LAKES, N.J., February 7, 2014 – BD (Becton, Dickinson and Company) (NYSE:BDX), a leading global technology company, today announced the appointment of Amit Bhalla as Vice President,...
-
Feb 7, 2014
BD (Becton, Dickinson and Company) (NYSE:BDX), a leading global medical technology company, announced today that it will present at the following investor healthcare conferences in February 2014:...
-
Feb 4, 2014-- Raises the bottom end of full fiscal year 2014 revenue and earnings ranges for guidance.
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today reported quarterly revenues of $2.0 billion for the first fiscal quarter ended December 31, 2013,...
-
Feb 3, 2014Second quarter revenue increased to $922 million, driven by continued strength in the company's Procedural Solutions segment
SAN DIEGO, CA, Feb. 3, 2014 /PRNewswire/ – CareFusion Corp. (NYSE: CFN), a leading, global medical technology company, today reported financial results for its second quarter of fiscal 2014,...
-
Jan 29, 2014CareFusion, Terumo Sign Distribution Agreement For IV Catheters
SAN DIEGO, CA, Jan. 29, 2014 /PRNewswire/ – CareFusion (NYSE:CFN), a leading global medical technology company, and Terumo Corporation, the largest medical technology company in Japan, today...
-
Jan 28, 2014
The Board of Directors of BD (Becton, Dickinson and Company) (NYSE: BDX) has declared a quarterly dividend of 54.5 cents per common share payable on March 31, 2014 to holders of record on March...
-
Jan 14, 2014
BD (Becton, Dickinson and Company) (NYSE: BDX), a global medical technology company, announced today that it will host a live webcast of its Annual Meeting of Shareholders on Tuesday, January 28,...
-
Jan 13, 2014BD MAX(TM) MRSA XT Assay with eXTended Detection Technology Receives FDA Clearance
BD Diagnostics, a segment of BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced today it has received FDA clearance to market the BD MAX(TM) MRSA XT
-
Jan 10, 2014
SAN DIEGO, CA, Jan. 9, 2014 /PRNewswire/ – CareFusion Corporation (NYSE: CFN) today announced plans to release second quarter fiscal 2014 results on Monday, Feb. 3, following the close of...
-
Jan 9, 2014
SAN DIEGO, CA, Jan. 9, 2014 /PRNewswire/ – CareFusion Corp. (NYSE: CFN) today issued the following statement regarding a previously disclosed settlement agreement: Today, the U.S. Department of...
-
Jan 7, 2014
BD (Becton, Dickinson and Company) (NYSE: BDX) announced today that it will conduct a live webcast of its first fiscal quarter 2014 earnings conference call on Tuesday, February 4, 2014, at 8:00...
-
Jan 7, 2014Advances BD Diagnostics' Point-of-Care Strategy
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced today that it has acquired Alverix, Inc., a privately-held diagnostic instrument company...
-
Jan 5, 2014In response to a recent media story regarding the validity of a CareFusion-funded clinical study, CareFusion issued the following statement:
Our products are safe and effective. In particular, our skin prep product, ChloraPrep, has been proven effective when used in conjunction with best clinical practices to effectively kill...